Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...

Tanzania recently reported its first two mpox cases, raising the number of affected countries to 23, officials from the ...

More than 200 community health agents have already been trained in Burundi to help control the spread of mpox as the ...

Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

A new mutated variant of Mpox has been identified in Democratic Republic of Congo, with health authorities concerned over ...

Health Minister Jenista Mhagama declared Marburg after six weeks since the last case in ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve ...